Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022

Michael Higgins Maintained (VRDN) at Strong Buy with Increased Target to $40 on, Aug 16th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-40-on-aug-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Higgins of Ladenburg Thalmann, Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy with Increased Target from $33 to $40 on, Aug 16th, 2022.

Michael has made no other calls on VRDN in the last 4 months.



There are 2 other peers that have a rating on VRDN. Out of the 2 peers that are also analyzing VRDN, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael


  • Mike Kratky of "SVB Leerink" Maintained at Buy with Increased Target to $40 on, Monday, August 15th, 2022
  • Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $25 on, Thursday, June 23rd, 2022

Publication Contributing Sources